123I-CMICE-013
N/A
Report date: 2025/12/01 17:16:53
NME
Base Information
Drug Name123I-CMICE-013
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNordion
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesOttawa Heart Institute Research Corporation -
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A